Company
Abbvie Inc
NYSE:ABBV
Abbvie Inc is a diversified research-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies.
44 stories · page 1 of 3
AT&T and Discovery raise US$30bn in bond offering
The debt offering is fourth highest in history as investors order more than £106bn
UK to open up biosimilar drugs market with change to rules
Around 80% of the most expensive drugs used by the NHS are biologics
Not too late for coronavirus vaccines, new drugs as outbreak “likely” to repeat
Experts say the most effective treatment for now would be repurposing existing drugs, but vaccines and new formulations are still welcome
Queensland Uni joins US biotechs in search for coronavirus vaccine
NASDAQ-listed Inovio Pharmaceuticals and Moderna have been awarded funds to develop a vaccine
Pharma stocks head south as Trump forces them to display drug prices in TV ads
“Drug companies have to come clean about their prices in TV ads. If drug companies are ashamed of those prices – lower them!”
Voyager Therapeutics stock flies after AbbVie collaboration
The collaboration is potentially valued at over $1 billion
US billionaire Robert Duggan to invest US$25mln into Summit Therapeutics
Duggan was the boss of Pharmacyclics and oversaw the company’s US$21bn sale to US pharma giant AbbVie back in 2015
EARLY MOVERS: The Children's Place shares sink on weak earnings; AbbVie slides after drug test cut short
Weak results and a suspension of a key drug test hits the stock of two companies as trading resumes in the US after a one-day break
US giant AbbVie to fund trial of genedrive's hep C test
genedrive thinks its simple out-reach test can help to cure hepatitis C in recovering heroin addicts, people who generally don’t like going to the doctors